Usefulness of biodegradable stents constructed of poly-/-lactic acid monofilaments in patients with benign esophageal stenosis

R5; AIM: To report 13 patients with benign esophageal stenosis treated with the biodegradable stent.METHODS: We developed a Ultraflex-type stent by knitting poly-l-lactic acid monofilaments.RESULTS: Two cases were esophageal stenosis caused by drinking of caustic liquid, 4 cases were due to surgical...

Full description

Saved in:
Bibliographic Details
Published in世界胃肠病学杂志(英文版) Vol. 13; no. 29; pp. 3977 - 3980
Main Authors Yasuharu Saito, Toyohiko Tanaka, Akira Andoh, Hideki Minematsu, Kazunori Hata, Tomoyuki Tsujikawa, Norihisa Nitta, Kiyoshi Murata, Yoshihide Fujiyama
Format Journal Article
LanguageEnglish
Published Department of Endoscopic Medicine, Shiga University of Medical Science, Seta Tukinowa, Otsu 520-2192,Japan%Department of Radiology, Shiga University of Medical Science, Seta Tukinowa, Otsu 520-2192, Japan%Department of Internal Medicine, Shiga University of Medical Science, Seta Tukinowa,Otsu 520-2192, Japan 07.08.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:R5; AIM: To report 13 patients with benign esophageal stenosis treated with the biodegradable stent.METHODS: We developed a Ultraflex-type stent by knitting poly-l-lactic acid monofilaments.RESULTS: Two cases were esophageal stenosis caused by drinking of caustic liquid, 4 cases were due to surgical resection of esophageal cancers, and 7 cases were patients with esophageal cancer who received the preventive placement of biodegradable stents for postendoscopic mucosal dissection (ESD) stenosis. The preventive placement was performed within 2 to 3 d after ESD. In 10 of the 13 cases, spontaneous migration of the stents occurred between 10 to 21 d after placement. In these cases, the migrated stents were excreted with the feces, and no obstructive complications were experienced. In 3 cases, the stents remained at the proper location on d 21 after placement. No symptoms of re-stenosis were observed within the follow-up period of 7 mo to 2 years. Further treatment with balloon dilatation or replacement of the biodegradable stent was not required.CONCLUSION: Biodegradable stents were useful for the treatment of benign esophageal stenosis, particularly for the prevention of post-ESD stenosis.
ISSN:1007-9327
DOI:10.3748/wjg.v13.i29.3977